Energy-requiring cell functions in the ischemic brain. Their critical supply and possible inhibition in protective therapy.
D000818:Animals; D001463:Barbiturates / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism*; D002545:Brain Ischemia / Q000378:metabolism*; D002463:Cell Membrane Permeability / Q000187:drug effects; D002544:Cerebral Infarction / Q000517:prevention & control; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004285:Dogs; D004569:Electroencephalography; D004734:Energy Metabolism; D005947:Glucose / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007036:Hypothermia, Induced; D008012:Lidocaine / Q000627:therapeutic use; D010042:Ouabain / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D011188:Potassium / Q000378:metabolism; D051381:Rats; D012964:Sodium / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects
D001463:Barbiturates; D010042:Ouabain; D008012:Lidocaine; D012964:Sodium; D005947:Glucose; D011188:Potassium